Markels John bought SGMO
June 4, 2024 · Form 4 insider transaction
Markels John bought 25,000 shares of Sangamo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderMarkels John
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 4, 2024
Filing dateJune 6, 2024
Shares owned after71,384
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant that will fully vest on the earlier of (a) June 4, 2025 or (b) the day prior to the 2025 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP")) through such date and subject to acceleration as provided in the 2018 EIP.